Travere Therapeutics, Inc. Profile Avatar - Palmy Investing

Travere Therapeutics, Inc.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of cheno…

Biotechnology
US, San Diego [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of TVTX's Analysis
CIK: 1438533 CUSIP: 89422G107 ISIN: US89422G1076 LEI: - UEI: -
Secondary Listings
TVTX has no secondary listings inside our databases.